206 related articles for article (PubMed ID: 24594477)
1. Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine.
O'Shea E; Urrutia A; Green AR; Colado MI
Neuropharmacology; 2014 Dec; 87():125-34. PubMed ID: 24594477
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9.
Martins T; Baptista S; Gonçalves J; Leal E; Milhazes N; Borges F; Ribeiro CF; Quintela O; Lendoiro E; López-Rivadulla M; Ambrósio AF; Silva AP
Brain Res; 2011 Sep; 1411():28-40. PubMed ID: 21803344
[TBL] [Abstract][Full Text] [Related]
3. Peripheral ammonia and blood brain barrier structure and function after methamphetamine.
Northrop NA; Halpin LE; Yamamoto BK
Neuropharmacology; 2016 Aug; 107():18-26. PubMed ID: 26972828
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors.
Rubio-Araiz A; Perez-Hernandez M; Urrutia A; Porcu F; Borcel E; Gutierrez-Lopez MD; O'Shea E; Colado MI
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1243-55. PubMed ID: 24626059
[TBL] [Abstract][Full Text] [Related]
5. A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine.
Urrutia A; Rubio-Araiz A; Gutierrez-Lopez MD; ElAli A; Hermann DM; O'Shea E; Colado MI
Neurobiol Dis; 2013 Feb; 50():49-58. PubMed ID: 23069681
[TBL] [Abstract][Full Text] [Related]
6. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia.
Kiyatkin EA; Brown PL; Sharma HS
Eur J Neurosci; 2007 Sep; 26(5):1242-53. PubMed ID: 17767502
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus.
Pérez-Hernández M; Fernández-Valle ME; Rubio-Araiz A; Vidal R; Gutiérrez-López MD; O'Shea E; Colado MI
Neuropharmacology; 2017 May; 118():157-166. PubMed ID: 28322979
[TBL] [Abstract][Full Text] [Related]
8. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
9. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.
Rosas-Hernandez H; Cuevas E; Lantz SM; Rice KC; Gannon BM; Fantegrossi WE; Gonzalez C; Paule MG; Ali SF
Neurosci Lett; 2016 Aug; 629():125-130. PubMed ID: 27320055
[TBL] [Abstract][Full Text] [Related]
11. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
Itzhak Y; Anderson KL; Ali SF
Ann N Y Acad Sci; 2004 Oct; 1025():119-28. PubMed ID: 15542708
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques.
Crean RD; Davis SA; Taffe MA
Pharmacol Biochem Behav; 2007 May; 87(1):11-9. PubMed ID: 17475314
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation.
Garcia-Ratés S; Camarasa J; Escubedo E; Pubill D
Toxicol Appl Pharmacol; 2007 Sep; 223(3):195-205. PubMed ID: 17614110
[TBL] [Abstract][Full Text] [Related]
14. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury.
Sharma HS; Ali SF
Ann N Y Acad Sci; 2008 Oct; 1139():242-58. PubMed ID: 18991870
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.
Ramirez SH; Potula R; Fan S; Eidem T; Papugani A; Reichenbach N; Dykstra H; Weksler BB; Romero IA; Couraud PO; Persidsky Y
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1933-45. PubMed ID: 19654589
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain barrier integrity.
Parikh NU; Aalinkeel R; Reynolds JL; Nair BB; Sykes DE; Mammen MJ; Schwartz SA; Mahajan SD
Brain Res; 2015 Oct; 1624():175-187. PubMed ID: 26236024
[TBL] [Abstract][Full Text] [Related]
17. Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown.
Gonçalves J; Leitão RA; Higuera-Matas A; Assis MA; Coria SM; Fontes-Ribeiro C; Ambrosio E; Silva AP
Brain Behav Immun; 2017 May; 62():306-317. PubMed ID: 28237710
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.
Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Adal A; Qi M; Toh J; Xu G; Prasad PN; Schwartz SA
Brain Res; 2008 Apr; 1203():133-48. PubMed ID: 18329007
[TBL] [Abstract][Full Text] [Related]
19. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D
Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077
[TBL] [Abstract][Full Text] [Related]
20. Brain imaging in methamphetamine-treated mice using a nitroxide contrast agent for EPR imaging of the redox status and a gadolinium contrast agent for MRI observation of blood-brain barrier function.
Emoto MC; Yamato M; Sato-Akaba H; Yamada K; Matsuoka Y; Fujii HG
Free Radic Res; 2015; 49(8):1038-47. PubMed ID: 25968953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
